References
- Marmé F, Schneeweiss A. Targeted Therapies in Triple-Negative breast cancer. Breast Care (Basel) 2015; 10:159-66; http://dx.doi.org/10.1159/000433622
- Wright HJ, Arulmoli J, Motazedi M, Nelson LJ, Heinemann FS, Flanagan LA, Razorenova OV. CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer. Oncogene 2016; http://dx.doi.org/10.1038/onc.2016.7
- Law ME, Corsino PE, Jahn SC, Davis BJ, Chen S, Patel B, Pham K, Lu J, Sheppard B, Nørgaard P, et al. Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms. Oncogene 2013; 32:1316-29; PMID:22543582; http://dx.doi.org/10.1038/onc.2012.138
- Uekita T, Sakai R. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci 2011; 102:1943-8; PMID:21812858; http://dx.doi.org/10.1111/j.1349-7006.2011.02052.x
- Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK, Krieg A, Bedogni B, LaGory E, Weissman IL, et al. VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration. Proc Natl Acad Sci U S A 2011; 108:1931-6; PMID:21233420; http://dx.doi.org/10.1073/pnas.1011777108
- Bork P, Beckmann G. The CUB domain. A widespread module in developmentally regulated proteins. J Mol Biol 1993; 231:539-45; PMID:8510165; http://dx.doi.org/10.1006/jmbi.1993.1305
- Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling. Oncogene 2014; 33:255-68; PMID:23208492; http://dx.doi.org/10.1038/onc.2012.547